KBC Group NV - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 145 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
KBC Group NV ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$40,000
-4.8%
2,0400.0%0.00%
Q2 2020$42,000
+250.0%
2,040
+100.0%
0.00%
Q1 2020$12,000
-20.0%
1,0200.0%0.00%
Q4 2019$15,000
-71.7%
1,020
-74.2%
0.00%
Q3 2019$53,000
+488.9%
3,960
+661.5%
0.00%
Q2 2019$9,0000.0%5200.0%0.00%
Q1 2019$9,000
+125.0%
520
+100.0%
0.00%
Q4 2018$4,000
-71.4%
260
-50.5%
0.00%
Q3 2018$14,0000.0%5250.0%0.00%
Q2 2018$14,000
+27.3%
5250.0%0.00%
Q1 2018$11,000
+10.0%
5250.0%0.00%
Q4 2017$10,0005250.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders